Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 2 of 2 entries
Sorted by: Best Match Show Resources per page
Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand.

Infection and drug resistance

Jaksuwan R, Tharavichikul P, Patumanond J, Chuchottaworn C, Chanwong S, Smithtikarn S, Settakorn J.
PMID: 28706448
Infect Drug Resist. 2017 Jun 10;10:167-174. doi: 10.2147/IDR.S130203. eCollection 2017.

BACKGROUND: Multidrug/extensively drug-resistant tuberculosis (M/XDR-TB) is a major public health problem, and early detection is important for preventing its spread. This study aimed to demonstrate the distribution of genetic site mutation associated with drug resistance in M/XDR-TB in the...

Cite
Jaksuwan R, Tharavichikul P, Patumanond J, et al. Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand. Infect Drug Resist. 2017;10:167-174doi: 10.2147/IDR.S130203.
Jaksuwan, R., Tharavichikul, P., Patumanond, J., Chuchottaworn, C., Chanwong, S., Smithtikarn, S., & Settakorn, J. (2017). Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand. Infection and drug resistance, 10167-174. https://doi.org/10.2147/IDR.S130203
Jaksuwan, Risara, et al. "Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand." Infection and drug resistance vol. 10 (2017): 167-174. doi: https://doi.org/10.2147/IDR.S130203
Jaksuwan R, Tharavichikul P, Patumanond J, Chuchottaworn C, Chanwong S, Smithtikarn S, Settakorn J. Genotypic distribution of multidrug-resistant and extensively drug-resistant tuberculosis in northern Thailand. Infect Drug Resist. 2017 Jun 10;10:167-174. doi: 10.2147/IDR.S130203. eCollection 2017. PMID: 28706448; PMCID: PMC5495008.
Copy Download .nbib Format: NLM
Bedaquiline Drug Resistance Emergence Assessment in MDR-TB (DREAM): a 5-Year Prospective In-Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug-Susceptibility Testing in MDR-TB Isolates.

Journal of clinical microbiology

Kaniga K, Hasan R, Jou R, Vasiliauskienė E, Chuchottaworn C, Ismail N, Metchock B, Miliauskas S, Viet Nhung N, Rodrigues C, Shin S, Simsek H, Smithtikarn S, Ngoc ALT, Boonyasopun J, Kazi M, Kim S, Kamolwat P, Musteikiene G, Sacopon CA, Tahseen S, Vasiliauskaitė L, Wu MH, Vally Omar S.
PMID: 34705538
J Clin Microbiol. 2021 Oct 27;JCM0291920. doi: 10.1128/JCM.02919-20. Epub 2021 Oct 27.

Bedaquiline Drug Resistance Emergence Assessment in Multidrug-resistant-tuberculosis (MDR-TB) (DREAM) was a 5-year (2015-2019) phenotypic drug-resistance surveillance study across 11 countries. DREAM assessed the susceptibility of 5036 MDR-TB isolates of bedaquiline-treatment-naïve patients to bedaquiline and other anti-tuberculosis drugs by the...

Cite
Kaniga K, Hasan R, Jou R, et al. Bedaquiline Drug Resistance Emergence Assessment in MDR-TB (DREAM): a 5-Year Prospective In-Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug-Susceptibility Testing in MDR-TB Isolates. J Clin Microbiol. 2021;JCM0291920doi: 10.1128/JCM.02919-20.
Kaniga, K., Hasan, R., Jou, R., Vasiliauskienė, E., Chuchottaworn, C., Ismail, N., Metchock, B., Miliauskas, S., Viet Nhung, N., Rodrigues, C., Shin, S., Simsek, H., Smithtikarn, S., Ngoc, A. L. T., Boonyasopun, J., Kazi, M., Kim, S., Kamolwat, P., Musteikiene, G., Sacopon, C. A., Tahseen, S., Vasiliauskaitė, L., Wu, M. H., & Vally Omar, S. (2021). Bedaquiline Drug Resistance Emergence Assessment in MDR-TB (DREAM): a 5-Year Prospective In-Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug-Susceptibility Testing in MDR-TB Isolates. Journal of clinical microbiology, JCM0291920. https://doi.org/10.1128/JCM.02919-20
Kaniga, Koné, et al. "Bedaquiline Drug Resistance Emergence Assessment in MDR-TB (DREAM): a 5-Year Prospective In-Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug-Susceptibility Testing in MDR-TB Isolates." Journal of clinical microbiology vol. (2021): JCM0291920. doi: https://doi.org/10.1128/JCM.02919-20
Kaniga K, Hasan R, Jou R, Vasiliauskienė E, Chuchottaworn C, Ismail N, Metchock B, Miliauskas S, Viet Nhung N, Rodrigues C, Shin S, Simsek H, Smithtikarn S, Ngoc ALT, Boonyasopun J, Kazi M, Kim S, Kamolwat P, Musteikiene G, Sacopon CA, Tahseen S, Vasiliauskaitė L, Wu MH, Vally Omar S. Bedaquiline Drug Resistance Emergence Assessment in MDR-TB (DREAM): a 5-Year Prospective In-Vitro Surveillance Study of Bedaquiline and Other Second-Line Drug-Susceptibility Testing in MDR-TB Isolates. J Clin Microbiol. 2021 Oct 27;JCM0291920. doi: 10.1128/JCM.02919-20. Epub 2021 Oct 27. PMID: 34705538.
Copy Download .nbib Format: NLM
Showing 1 to 2 of 2 entries